Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]
ESMO Open. 2025 Jan;10(1):104074.
doi: 10.1016/j.esmoop.2024.104074.
Epub 2024 Dec 19.
1 Kaohsiung Medical University Hospital, Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. Electronic address: leochen@nhri.org.tw.
2 Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany; Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
3 Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
4 Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
5 Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
6 Haematology Medical Oncology Division, Department of Oncology, Faculty of Medicine, Diponegoro University/Dr. Kariadi Hospital, Semarang, Indonesia.
7 Department of Medical Oncology, Max Institute of Cancer Care, Max Super Specialty Hospital, Saket, New Delhi, India.
8 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
9 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
10 Department of Oncology and Nuclear Medicine, Thomson Hospital Kota Damansara, Petaling Jaya, Selangor, Malaysia.
11 Clinical Division Building, University of Santo Tomas Hospital, Sampaloc, Manila, Philippines.
12 Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
13 Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok.
14 Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
15 Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
16 Department of Internal Medicine, Metro Davao Medical and Research Center, Davao City, The Philippines; Section of Medical Oncology, Department of Internal Medicine, Southern Philippines Medical Center, Davao City, The Philippines.
17 Department of Oncology, Curie Oncology Kuala Lumpur, Kuala Lumpur, Malaysia.
18 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
19 Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
20 Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, India.
21 Division of Digestive Surgery, Department of General Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
22 Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
23 Istituto Europeo di Oncologia, Milano, IRCCS, Milano, Italy; Department of Oncology and Haematology, University of Milano, Milano, Italy.
24 Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
25 Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
26 ESMO, Lugano, Switzerland.
27 Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC. Instituto de Salud Carlos III, Madrid, Spain.
28 Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
29 INSERM U1279, Université Paris-Saclay, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.